FDA again warns of Internet drug sales

Jul 03, 2007

The U.S. Food and Drug Administration issued another warming Monday about the dangers of buying medications via the Internet.

FDA officials said new data show consumers are continuing to buy drugs from Internet outlets in an attempt to save money on expensive prescription drugs sold in the United States.

But the FDA said people don't need to take chances by buying prescription drugs from Internet sites, because low-cost generic versions are available in the United States.

"This finding also may be an indication that some consumers are likely buying foreign drugs this way to avoid getting a prescription from their doctor or health care professional, since many Web sites do not require a prescription," the government agency said.

Officials said consumers should be aware of safety concerns of drugs purchased from unregulated Internet sellers.

Copyright 2007 by United Press International

Explore further: Japan's Takeda offers $2.2 bn to settle US drug lawsuits

Related Stories

Investors to get Google records on online drug ads

Mar 09, 2012

(AP) -- A Delaware judge has given Google Inc. until April 9 to give a pension fund investors company documents involving what authorities said was the illegal online marketing of prescription drugs to U.S. consumers by ...

'Internet of Things' seen as tech industry's next big driver

Jan 08, 2014

Billions of ordinary things - from farm cows and factory gear to pollution monitors and prescription-drug bottles - are being outfitted with microchips and linked by online networks in a technological transformation that ...

RI to get $230M from $500M Google forfeiture

Apr 02, 2012

(AP) -- Rhode Island law enforcement agencies that participated in an investigation that resulted in Google Inc. forfeiting $500 million last year will receive $230 million of that money, federal officials said Monday.

Recommended for you

Japan's Takeda offers $2.2 bn to settle US drug lawsuits

22 hours ago

Japan's top drugmaker Takeda Pharmaceutical has offered $2.2 billion to settle US claims linked to its diabetes drug Actos, in what would be one of the biggest US payouts over patient lawsuits, a report said Wednesday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.